Hot Life Science Investor Mandate 20: VC/Incubator Seeking Early Stage Israeli Devices

4 Jun

A venture capital/incubation firm supports about 5 new early-stage life science companies per year, and provides two years of funding in return for equity.  Funding is only available to Israel-based companies; in cases where entrepreneurs based outside Israel would like to establish a company in Israel, an Israeli CEO/project manager is recruited by the firm.

The firm incubates medical device companies, and focuses on very early-stage ventures, including devices at or before the patent application stage; in such cases, the firm will help the innovator form a company and a management team.  The firm focuses on minimally invasive devices, and has experience of investing in cardiovascular devices, ophthalmology, orthopedic devices, laproscopic devices, and many other fields.  The firm is open to investing in any indication area.

The firm invests in companies targeting unmet medical needs with large markets, and seeks to invest in good management teams.  The firm prefers to invest in ventures that require $5m or less of R&D spending to reach the market.  As the the program provides funding for 2 years, the firm also helps its portfolio companies find additional funding to support future development.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: